Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 10 | 2026 | 760 | 1.580 |
Why?
|
| Genetic Therapy | 12 | 2026 | 852 | 1.510 |
Why?
|
| Genetic Vectors | 8 | 2026 | 930 | 1.350 |
Why?
|
| Prealbumin | 6 | 2021 | 21 | 1.150 |
Why?
|
| Cockayne Syndrome | 1 | 2026 | 5 | 0.970 |
Why?
|
| Huntington Disease | 2 | 2025 | 164 | 0.820 |
Why?
|
| Amyloidosis | 2 | 2021 | 70 | 0.740 |
Why?
|
| Transduction, Genetic | 2 | 2019 | 242 | 0.670 |
Why?
|
| Amyloid Neuropathies, Familial | 4 | 2014 | 20 | 0.660 |
Why?
|
| Gene Expression | 3 | 2020 | 856 | 0.630 |
Why?
|
| Gene Editing | 2 | 2022 | 331 | 0.630 |
Why?
|
| Antigens, Ly | 1 | 2019 | 44 | 0.610 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 99 | 0.580 |
Why?
|
| Central Nervous System | 2 | 2019 | 205 | 0.560 |
Why?
|
| Tay-Sachs Disease | 3 | 2025 | 55 | 0.420 |
Why?
|
| Membrane Proteins | 1 | 2019 | 926 | 0.400 |
Why?
|
| Lysosomes | 1 | 2013 | 176 | 0.360 |
Why?
|
| Liver | 2 | 2014 | 875 | 0.350 |
Why?
|
| Gene Transfer Techniques | 3 | 2019 | 325 | 0.350 |
Why?
|
| Disease Models, Animal | 7 | 2026 | 2329 | 0.310 |
Why?
|
| Mice | 11 | 2026 | 11184 | 0.310 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 1292 | 0.310 |
Why?
|
| Animals | 14 | 2026 | 21492 | 0.260 |
Why?
|
| Transgenes | 3 | 2023 | 207 | 0.260 |
Why?
|
| Xeroderma Pigmentosum Group A Protein | 1 | 2026 | 4 | 0.250 |
Why?
|
| Hexosaminidase A | 1 | 2025 | 6 | 0.230 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 20 | 0.230 |
Why?
|
| Zinc Fingers | 1 | 2025 | 105 | 0.220 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2024 | 15 | 0.210 |
Why?
|
| Huntingtin Protein | 1 | 2025 | 151 | 0.210 |
Why?
|
| Heterozygote | 1 | 2024 | 175 | 0.200 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 227 | 0.200 |
Why?
|
| Dystrophin | 1 | 2023 | 30 | 0.200 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 46 | 0.190 |
Why?
|
| Lipids | 1 | 2025 | 331 | 0.190 |
Why?
|
| Genes, Reporter | 2 | 2019 | 257 | 0.180 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2022 | 26 | 0.180 |
Why?
|
| Mice, Knockout | 1 | 2026 | 2168 | 0.170 |
Why?
|
| Humans | 13 | 2026 | 65843 | 0.160 |
Why?
|
| Sandhoff Disease | 1 | 2020 | 38 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 152 | 0.150 |
Why?
|
| Cisterna Magna | 1 | 2019 | 17 | 0.150 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 82 | 0.150 |
Why?
|
| Polyneuropathies | 2 | 2010 | 13 | 0.150 |
Why?
|
| Species Specificity | 1 | 2019 | 344 | 0.140 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 180 | 0.140 |
Why?
|
| Genotype | 1 | 2019 | 676 | 0.130 |
Why?
|
| Brain | 1 | 2025 | 1672 | 0.120 |
Why?
|
| Male | 4 | 2026 | 31410 | 0.110 |
Why?
|
| Peripheral Nervous System | 1 | 2014 | 13 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 37 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2014 | 129 | 0.110 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2014 | 39 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2014 | 53 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 65 | 0.100 |
Why?
|
| G(M2) Ganglioside | 2 | 2025 | 15 | 0.100 |
Why?
|
| Choroid Plexus | 1 | 2013 | 16 | 0.100 |
Why?
|
| Glycosylation | 1 | 2013 | 139 | 0.090 |
Why?
|
| Sheep | 2 | 2025 | 194 | 0.090 |
Why?
|
| Mutation | 4 | 2025 | 2674 | 0.090 |
Why?
|
| Proteomics | 1 | 2014 | 299 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2013 | 225 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 174 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2013 | 617 | 0.080 |
Why?
|
| Propanolamines | 1 | 2010 | 10 | 0.080 |
Why?
|
| Carbazoles | 1 | 2010 | 13 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 240 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 309 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2010 | 152 | 0.070 |
Why?
|
| Biomarkers | 2 | 2022 | 1503 | 0.070 |
Why?
|
| Apoptosis | 3 | 2010 | 1099 | 0.070 |
Why?
|
| Cell Line | 1 | 2013 | 2031 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1572 | 0.070 |
Why?
|
| Taurochenodeoxycholic Acid | 1 | 2008 | 3 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 252 | 0.070 |
Why?
|
| Amyloidosis, Familial | 1 | 2007 | 2 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1635 | 0.070 |
Why?
|
| Coccidiosis | 1 | 2007 | 1 | 0.060 |
Why?
|
| Neospora | 1 | 2007 | 1 | 0.060 |
Why?
|
| Antibodies, Protozoan | 1 | 2007 | 59 | 0.060 |
Why?
|
| beta-Hexosaminidase beta Chain | 1 | 2025 | 8 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2024 | 5 | 0.050 |
Why?
|
| Alleles | 1 | 2025 | 455 | 0.050 |
Why?
|
| Models, Animal | 2 | 2019 | 243 | 0.050 |
Why?
|
| Locomotion | 1 | 2024 | 111 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2023 | 122 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 188 | 0.050 |
Why?
|
| G(M1) Ganglioside | 1 | 2022 | 12 | 0.050 |
Why?
|
| Gangliosides | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cats | 1 | 2022 | 92 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 2022 | 84 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2022 | 292 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1236 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 104 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 3506 | 0.040 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2020 | 19 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2019 | 44 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 56 | 0.040 |
Why?
|
| Catheters | 1 | 2019 | 83 | 0.040 |
Why?
|
| Video Recording | 1 | 2019 | 140 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 235 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2010 | 328 | 0.030 |
Why?
|
| Female | 1 | 2019 | 34424 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2023 | 829 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2010 | 323 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 737 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 899 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 1266 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1663 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2324 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 181 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 57 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 103 | 0.020 |
Why?
|
| fas Receptor | 1 | 2008 | 56 | 0.020 |
Why?
|
| Tyrosine | 1 | 2008 | 93 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 71 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2008 | 200 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2008 | 100 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 180 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 312 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2008 | 187 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 17579 | 0.010 |
Why?
|
| DNA Damage | 1 | 2007 | 298 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 869 | 0.010 |
Why?
|